HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours

[1]  D. O’Connell,et al.  Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction , 2016, Cancer.

[2]  H. Zou,et al.  Positivity and incidence of human papillomavirus in women attending gynecological department of a major comprehensive hospital in Kunming, China 2012–2014 , 2016, Journal of medical virology.

[3]  C. Chung,et al.  Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma. , 2015, JAMA oncology.

[4]  J. Califano,et al.  Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer. , 2014, JAMA otolaryngology-- head & neck surgery.

[5]  M. Hasegawa,et al.  A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma , 2014, International journal of oncology.

[6]  L. Konge,et al.  Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review , 2014, British Journal of Cancer.

[7]  B. Graubard,et al.  Prevalence of oral HPV infection in the United States, 2009-2010. , 2012, JAMA.

[8]  Esther Kim,et al.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  C. Rudack,et al.  Prevalence and impact on clinicopathological characteristics of human papillomavirus‐16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma , 2011, Head & neck.

[10]  S. Lippman,et al.  Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC) , 2010, Head & neck oncology.

[11]  Steven S. Chang,et al.  Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma. , 2008, Oral oncology.

[12]  A. Cmelak,et al.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.

[13]  Carole Fakhry,et al.  Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.

[14]  A. Carvalho,et al.  Feasibility of quantitative PCR‐based saliva rinse screening of HPV for head and neck cancer , 2005, International journal of cancer.

[15]  S. Tyring,et al.  Nested PCR with the PGMY09/11 and GP5(+)/6(+) primer sets improves detection of HPV DNA in cervical samples. , 2004, Journal of virological methods.

[16]  H. Hausen.  Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature Reviews Cancer.

[17]  K. Shah,et al.  Human papillomavirus–associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers , 2001, Current opinion in oncology.

[18]  D. Sidransky,et al.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.

[19]  David R. Scott,et al.  Improved Amplification of Genital Human Papillomaviruses , 2000, Journal of Clinical Microbiology.

[20]  A. Olshan,et al.  Human Papillomavirus and head and neck cancer: Epidemiology and molecular biology , 1998, Head & neck.

[21]  A. Reingold,et al.  Genital human papillomavirus infection in female university students as determined by a PCR‐based method , 1991, JAMA.

[22]  A. Levine,et al.  Association of human papillomavirus types 16 and 18 E6 proteins with p53. , 1990, Science.

[23]  K. Münger,et al.  The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.

[24]  Biological agents. Volume 100 B. A review of human carcinogens. , 2012, IARC monographs on the evaluation of carcinogenic risks to humans.

[25]  N. Khardori.  Prevalence of Oral HPV Infection in the United States, 2009-2010 , 2012 .